Table 5.
GOLD1 (≥80 FEV1%) | GOLD2 (50–79 FEV1%) | MORE SEVERE (<50 FEV1%)a | |
---|---|---|---|
Number of patients | 6 | 9 | 7 |
Mean age (years) | 57.3 (7.6) | 62.3 (7.1) | 59.5 |
Average height (cm) | 154.3 (18.6) | 163.5 (3.2) | 171.3 (8.2) |
Average weight (kg) | 78.8 (17.1) | 86.4 (30.8) | 74.3 (19.9) |
Average 6WMD (m) | 306.3 (38.1) | 208.7 (67.5) | 232.8 (65.2) |
Our experiment covered 30 patients with chronic obstructive pulmonary disease and/or chronic asthma. Of these, 25 patients reported both a 6-minute walk distance and percentage forced expiratory volume in 1 second (FEV1%). Although gender is a significant factor, we could only analyze the female demographic because we had 22 females and only 3 males. Data are mean or average (standard deviation) values.
Because individuals with a Global Initiative for Chronic Obstructive Lung Disease (GOLD) rating of 3 and 4 have difficulty walking, these were combined into a “more severe” category.